ES | EN
A healthcare professional talking with a patient during an appointment

Frequently Asked Questions

Answers to the most common questions about our sequencing and genetic testing services.

Whole-Genome-
-Sequencing

See Whole Genome Sequencing
¿PCR-Free or with a PCR test?

If you have at least 500 ng of good-quality DNA, we recommend PCR-Free: Coverage is more uniform, and variant detection is better. If the DNA is scarce or degraded, as in FFPE, a PCR-based library is the appropriate choice.

On which platform are my samples sequenced?

In DNBSEQ-G400 (MGI) or on the NovaSeq X (Illumina). We recommend the most efficient option based on the number of samples, the coverage you need, and your project timeline.

What kind of coverage do I need?

We recommend 30x (90 Gb for humans) for the study of germline variants. For other experimental designs, such as tumor samples or different species, we can advise you on how to adjust the output.

Do you work with non-human species?

Yes, with animal samples; in rats and mice, 30x is equivalent to 75–90 Gb. For other species,
Contact us.

How do I receive the data?

It depends on the total volume of data generated by the project. When the total output is small, as in the case of bacterial WGS, the FASTQ files are delivered via our server. For human genomes, where each sample generates a very large volume of data, delivery is made on a hard drive.

Can I order just the sequencing?

Yes. Bioinformatics analysis is optional and can be added later using the same data. We can also analyze FASTQ, BAM, or VCF files generated on Illumina and MGI platforms.

Whole-Exome-
-Sequencing

See Whole Exome Sequencing
Agilent SureSelect V8 or Agilent SureSelect CRE V4?

The Agilent SureSelect Human All Exon V8 probe covers coding regions and is the gold standard for research. The Agilent SureSelect Clinical Research Exome V4 probe, on the other hand, adds disease-associated noncoding regions, mitochondrial DNA, and minigenomes in 41 genes, making it the preferred choice when the study has a clinical focus or seeks the broadest coverage of relevant regions.

What kind of coverage do I need?

We recommend coverage on-target greater than 100x, which is achieved with approximately 12 Gb using the Agilent SureSelect Human All Exon V8 probe and 14 Gb using the Agilent SureSelect Clinical Research Exome V4 probe. For other designs, we can advise you on how to adjust the output.

Do you work with animal samples?

Yes. Specific libraries are used for rats, mice, and other species; please contact us to discuss the design.

How do I receive the data?

It depends on the total volume of data generated by the project. FASTQ files are typically delivered via our server; for projects with a large number of samples, delivery
is made via hard drive.

Can I order just the sequencing?

Yes. Bioinformatics analysis is optional and can be added later using the same data. We can also analyze FASTQ, BAM, or VCF files generated on Illumina and MGI platforms.

Do you offer exome sequencing for diagnostic purposes?

Yes. For the genetic diagnosis of patients, we offer a wide range of targeted exome tests across ten medical specialties, in addition to the DG Exome® whole-exome test, which is also available as a trio test (DG Exome Trio®), with a clinical report interpreted by our geneticists.

RNA Sequencing

See RNA Sequencing
Total RNA-Seq or mRNA-Seq?

If your goal is to study the differential expression of coding genes, mRNA-Seq is the most efficient option. Total RNA-Seq It also allows for the analysis of non-coding RNA and is the recommended option for degraded or FFPE samples.

How many samples do I need per condition?

For differential expression analysis, we recommend a minimum of 3 biological replicates per condition. Replicates allow you to account for natural variability among samples and provide the statistical power needed to detect reliable changes in expression. If you expect small differences or your samples are heterogeneous, it is advisable to increase the number of replicates. We can help you define your experimental design before you begin.

Can I send FFPE samples?

Yes, with at least 500 ng of RNA and a DV200 ≥70%. For FFPE samples, we recommend
Total RNA-Seq.

Do you work with non-human species?

Yes. Total RNA-Seq and miRNA-Seq accept human, animal, plant, and microorganism samples; mRNA-Seq, humans, animals, and plants.

How do I send the samples?

RNA must be shipped on dry ice. We coordinate shipping so that the samples arrive at our laboratory in less than 24 hours. If you prefer, we can perform the extraction from various types of biological samples.

How do I receive the data?

It depends on the total volume of data generated by the project. FASTQ files are typically delivered on a hard drive; for projects with a small total output, delivery can be made via our server.

Can I order just the sequencing?

Yes. Bioinformatics analysis is optional and can be added later to the same data. We can also analyze data generated on Illumina and MGI platforms.

Genetic diagnosis

How to Request a Study
Who can request a study?

Tests must be ordered by a healthcare professional, who receives the report and interprets it within the patient's clinical context.

How do I know which program to apply for?

Our geneticists will help you choose the most appropriate test based on your phenotype, family history, and clinical suspicion. You can also browse our catalog by specialty or search for a specific gene.

What is the deadline for submitting the report?

It depends on the test. Targeted exome sequencing has a turnaround time of 30 business days, and tests using other molecular techniques take 20 to 30 business days.

How do I send the sample?

We coordinate sample collection at your facility at no additional cost. The sample can be shipped at room temperature or refrigerated, along with the request form and the informed consent form.

What happens if the result includes a variant with an uncertain meaning?

Variants with uncertain significance are reevaluated 12 months after the report is issued. If their classification changes, we issue a new report; if not, we send an email to the requesting physician confirming that the variant has been reviewed and that its classification has not changed.

Can a study that has already been conducted be reanalyzed?

Yes. The exome data are stored and can be reanalyzed if new symptoms appear, if you wish to expand the study to include other genes, or if a family member is diagnosed with an inherited disease.